A team of our scientists at University College London have developed a potential new immunotherapy drug and caused another paradigm shift in our understanding of how cancer immunotherapy works.
We’re calling on UK governments to stand by their commitments to improving cancer survival and make sure everyone can receive the care they deserve.
As coronavirus cases continue to rise in the UK, we look at how cancer clinical trials have been affected by the pandemic.
We’ve partnered with the National Cancer Institute in the US (NCI) to stimulate even more innovative research collaborations through Cancer Grand Challenges.
Understanding why children get cancer is a huge task and extremely complex. In our latest Science Surgery, we spoke with Dr Francis Mussai about the differences between children and adult’s cancers.
Today’s new figures, from the UK’s National Cancer Research Institute, project a devastating 24% drop in the UK’s overall cancer research spending this year, driven by a 46% fall in charity sector funding.
We spoke to 3 members of the global STORMing Cancer team about their work to solve the mystery of inflammation and cancer.
We spoke to Professor Lou Chesler and Dr Lynley Marshall about the innovative studies that are aiming to make children’s cancer treatment more tailored.
We spoke to the team looking into the complex relationship between the gut microbiome and radiosensitisation in bladder cancer.